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M ore than 90% of maternal deathsworldwide occur in sub-Saharan
Africa (SSA) and south Asia. These high
maternal and associated neonatal mor-
tality rates persist despite considerable
efforts from the World Health Organi-
zation, governments, development
partners, and others.1-3 The majority of
these deaths are related to pregnancy
complications that are inadequately
managed because of a lack of access to
emergency health care. The maternal
mortality ratios (MMRs) of Sweden,
the United Kingdom, and the United
States are 4, 12, and 21, respectively,
whereas those of Chad, Nigeria, and
Congo are 1100, 630, and 540 per 100,000
live births, respectively. In SSA, the major
direct causes of maternal mortality are
hemorrhage, preeclampsia/eclampsia,
obstructed labor, and sepsis.4 Infections,
preterm birth, birth asphyxia, stillbirths,
and small-for-gestational-age infants
are the leading causes of perinatal
mortality.2,5
These observations are representative
of our own institution, Mulago Hospital
in Kampala (Uganda) inwhich theMMR
has remained high at 438 per 100,000
live births, even though there has been
an increase in skilled birth attendance
(58%) and very good attendance rate
(95%) at antenatal clinics.6
Mulago Hospital is the busiest ma-
ternity hospital in SSA, serving as a ter-
tiary referral center for Uganda. Details
of deliveries and maternal deaths are
shown in Table 1. Even with the lack
of good medical records that is charac-
teristic of much of SSA, our experience
in Mulago Hospital is that causes of
maternal deaths are similar to the rest
of SSA, with hemorrhage, preeclampsia/
eclampsia, and sepsis occurring very
commonly.4,7,8 The large number of
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Maternal and associated neonatal mortality rates in sub-Saharan Africa remain unac-
ceptably high. In Mulago Hospital (Kampala, Uganda), 2 major causes of maternal death
are preeclampsia and obstructed labor and their complications, conditions occurring at
the extremes of the birthweight spectrum, a situation encapsulated as the obstetric
dilemma. We have questioned whether the prevalence of these disorders occurs more
frequently in indigenous African women and those with African ancestry elsewhere in the
world by reviewing available literature. We conclude that these women are at greater risk
of preeclampsia than other racial groups. At least part of this susceptibility seems in-
dependent of socioeconomic status and likely is due to biological or genetic factors.
Evidence for a genetic contribution to preeclampsia is discussed. We go on to propose
that the obstetric dilemma in humans is responsible for this situation and discuss how
parturition and birthweight are subject to stabilizing selection. Other data we present also
suggest that there are particularly strong evolutionary selective pressures operating
during pregnancy and delivery in Africans. There is much greater genetic diversity and
less linkage disequilibrium in Africa, and the genes responsible for regulating birthweight
and placentation may therefore be easier to define than in non-African cohorts. Inclusion
of African women into research on preeclampsia is an essential component in tackling
this major disparity of maternal health.
Key words: evolutionary selective pressure, great obstetric syndromes, length of
gestation, obstetric dilemma
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women seen with preeclampsia, partic-
ularly recurrent, severe, and early-onset
preeclampsia and eclampsia, is of par-
ticular concern to us because these
conditions have a high mortality and
morbidity, are impossible to predict,
and their pathogenesis is still somewhat
mysterious.
Here we review data relating to pre-
eclampsia in indigenous Africans and in
women of African ancestry elsewhere
in the world. We discuss the idea that in
these women, apart from the obvious,
cultural and socioeconomic factors and
different priorities in health care, there
are additional biological reasons why the
preeclampsia syndromes are such a
prominent feature of African obstetrics.
Our ﬁndings also lead us to question
whether there are other characteristics of
pregnancy and parturition that differ in
African women.
Preeclampsia and the great obstetric
syndromes
An important determinant of preeclamp-
sia is failure of placentation, particularly
the physiological transformation of spi-
ral arteries, which leads to a stressed,
underperfused placenta.9,10 Preeclamp-
sia is one of a spectrum of pregnancy
disorders that may result from this un-
derlying pathogenesis, including fetal
growth restriction (FGR), stillbirth,
abruptio placentae, and some cases of
preterm labor with intact membranes
and prelabor rupture of membranes.11,12
Because of the overlap in these condi-
tions, it is useful to think of them to-
gether as the great obstetric syndromes
(GOS) (Appendix).13-15
All these conditions are seen very
frequently inMulago Hospital. However,
FGR cannot be reliably diagnosed
without accurate knowledge of gesta-
tional age, and low birthweight may
result from a variety of causes. Similarly,
stillbirth is a heterogeneous condition
that can result from congenital infection,
birth asphyxia, or birth trauma as well as
poor uteroplacental perfusion.
Because preeclampsia is a recognized
clinical entity characterized by new
onset of hypertension and proteinuria
after 20 weeks’ gestation, we have
focused on this disorder.16,17 The exact
prevalence of preeclampsia in SSA is
unknown because detailed clinical re-
cords of all births are lacking. Dis-
tinguishing between true preeclampsia
and pregnancy-induced hypertension is
also difﬁcult because proteinuria may
not be adequately measured. A further
problem is a lack of information on
preexisting hypertension because pre-
sentation to the clinic is often late.
Given this dearth of accurate records
of pregnancy outcomes in Uganda and
SSA generally, to review the incidence
of preeclampsia in women of African
ancestry, we have reviewed reports re-
lating to preeclampsia in African Amer-
icans (AA) and immigrants from Africa
to other high-income countries as
compared with other ethnic groups.
Studies were identiﬁed through a search
of the PubMed database for relevant
peer-reviewed articles published in En-
glish using the search terms, pre-
eclampsia or eclampsia or hypertensive
disease in pregnancy or gestational hy-
pertension or severe maternal morbidity
and ethnicity or race (Tables 2 and 3).
In this review, we designate women
of African ancestry as those women
descended from inhabitants of SSA.
There are obvious caveats when reviewing
data fromwomen of African descent who
have migrated to new environments.
Those who have the energy to migrate
may be healthier than those left behind.
Furthermore, factors such as diet, life-
style, education, health care, climate, and
indigenous pathogens are different and
necessarily become an integral part of
the immigrant’s new environment.
Preeclampsia among African
Americans
Although African Americans are obvi-
ously not directly comparable with
indigenous Africans because of consid-
erable genetic admixture (7-23%),18,19
the large number of reports and the
consistency of the ﬁndings are informa-
tive (Table 2). For decades it has been
clear that there are disparities in obstet-
ric outcomes including preeclampsia
between AA and other groups; indeed,
black ethnicity is cited as a risk factor
for preeclampsia in reviews.20,21 Of 4
million births recorded in the National
Vital Statistics Report, pregnancy-
associated hypertension was more com-
mon in AA (5.0%) and least frequent in
Hispanics (2.9%).22
A study of more than 2 million preg-
nancies in New York using data from
hospital discharge records found that
the rates of preeclampsia were substan-
tially higher among AA compared with
European Americans. This was even
more obvious when confounders such as
diabetes and maternal age were taken
into account. Furthermore, the differ-
ence persisted after stratiﬁcation for
socioeconomic status based on area of
residence.23
Two other large studies in the United
States, each with more than 1 million
women also found that preeclampsia was
more common in AA compared with
European Americans.24,25 One of these
studies took data from the National
Inpatient Sample in which information
was also available on health insurance
and income level; when this was taken
TABLE 1
Data for the maternity unit in Mulago Hospital, Uganda
Variable 2009 2010 2011
Live births 30,247 31,585 32,633
Stillbirths 1260 1303 1230
Cesarean sections 6849 6702 6800
Ruptured uterus 125 119 206
Maternal deaths 187 152 188
Attendance at antenatal clinic 78,157 76,673 69,129
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into account, the ﬁndings remained the
same.24 The other study used data from
women who were all Medicaid enrollees
in 14 southern states.25 AA women were
also most likely to have other poor
maternal outcomes like preterm labor,
abruptio placenta, and stillbirth.
Another large study from the National
Hospital Discharge Survey found AA
women had a higher incidence of all
hypertensive disorders in pregnancy and
a greater risk of severe complications of
preeclampsia such as abruptio placenta
and stillbirth compared with European
Americans.26 Similar ﬁndings were made
in a largeWisconsin study recruited from
hospital discharge data. AA women had
the highest risk for all the different types
of preeclampsia when compared with
European American women.27 Several
other studies looking at risk factors
for both eclampsia and preeclampsia
in nulliparous and parous women have
also shown AA are at higher risk
(Table 2).28-36
Confounding factors such as obesity,
preexisting chronic hypertension, and
diabetes are difﬁcult to control for and
are likely to contribute to the increased
risk of preeclampsia among AA, partic-
ularly in the case of chronic hyperten-
sion.37-39 That preeclampsia may not be
wholly explained by higher rates of
chronic hypertension among AA women
is suggested by a comparison between
African and European Americans without
chronic hypertension; the prevalence of
hypertension in pregnancy was similar,
but AA women still had an increased
diagnosis of preeclampsia.40 Similar
ﬁndings were made much earlier by the
Collaborative Perinatal project, which
revealed a higher incidence of pre-
eclampsia and eclampsia among AA
women compared with their European
counterparts, irrespective of whether
there was preexisting hypertension.41
Investigation of the GOS other than
preeclampsia is more difﬁcult because
of the problems in accurate diagnosis
described above. Nonetheless, a consis-
tent message is that ethnic disparities
exist for all the GOS (spontaneous pre-
term labor, FGR, stillbirth, and other
poor obstetric outcomes), and all have an
increased frequency among AA.26,42-45
In a study of more than 5 million
births comparing birth outcomes be-
tween US-born and foreign-born
women, women of African ancestry
had the highest rates of infant mor-
tality, low birthweight, and preterm
births, whether US born or foreign
TABLE 2
Preeclampsia or eclampsia studies among African Americans
Cohort size (total/AA)
Preeclampsia or
eclampsia, OR (95% CI) Comments Reference
2,571,069/450,098 1.67 (1.64e1.71)a PE in women in New York state 23
1,030,350/161,780 1.59 (1.49e1.69) Adjusted for maternal characteristics and obstetric history 24
1,472,912/420,576 1.30 (1.28e1.33) Adjusted for maternal characteristics and obstetric history 25
299,499/n.a. 1.39 (1.26e1.54)a Severe PE in women without chronic hypertension 26
206,428/19,512 2.12 (1.85e2.42) Adjusted for maternal characteristics and obstetric history 27
330/124 2.25 (0.88e5.78) Eclampsia, adjusted for maternal characteristics and obstetric history 29
4702/740 1.40 (1.20e1.80) Adjusted for maternal characteristics and obstetric history 30
271/38 2.50 (0.97e6.40) Adjusted for maternal characteristics and obstetric history 31
4314/1998 1.23 (0.88e1.72) Adjusted for maternal characteristics and obstetric history 32
153/35 2.27 (1.26e5.92) Late postpartum PE, not adjusted 33
2394/592 1.53 (1.00e2.35) Adjusted for maternal characteristics, obstetric history, and biochemical factors 34
103,860/13,748 1.36 (1.27e1.45)a PE in women with singleton birth at first delivery 35
2,770,871/121,017 1.81 (1.51e2.17) Eclampsia, adjusted for maternal characteristics and obstetric history 36
127,544/12,639 1.41 (1.25e1.62) Adjusted for maternal characteristics, chronic hypertension excluded 28
16,300/6000 1.63 (1.58e1.69)a Eclampsia in racial minorities, not adjusted, not significant 38
1355/374 3.20 (1.04e9.93) PE in women without chronic hypertension 40
500/68 2.29 (1.16e4.53) Recurrent PE, adjusted for maternal characteristics and obstetric history 67
10,755/5555 1.30 (1.07e1.58) Adjusted for maternal characteristics 44
2947/156 1.62 (0.00e3.20) No effect when analyzed by recruitment center 69
Maternal characteristics generally include maternal age, body mass index, and smoking. Obstetric history generally includes parity, chronic hypertension, and diabetes.
CI, confidence interval; n.a., not available; OR, odds ratio; PE, preeclampsia.
a OR was calculated from the data.
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born.46 In addition, the risk of pre-
term birth, stillbirth, and low birth-
weight is increased not only in AA
women but also with AA fathers.47,48
Explanations for the disparities found
between women with African or Euro-
pean ancestry have been poor socioeco-
nomic status with lower incomes and
level of education, lack of medical in-
surance, poor utilization of precon-
ception and antenatal services, stress,
discrimination, and residential segre-
gation. Several reports have tried to
determine the impact of these factors;
for example, women of African ancestry
were at an increased risk of pre-
eclampsia in a second pregnancy, but
this was not associated with Medicaid
enrollment.30
Many of the socioeconomic factors
that may contribute to poor obstetric
outcomes also apply to the Hispanic
population in the United States, yet
several studies have noted that pre-
eclampsia, low birthweight, and still-
birth are similar or even better than for
white women, the Hispanic paradox.28,44
Using information from the Duke Uni-
versity Birth Database, AA women had
higher rates of preeclampsia (10.2%)
than the European (8%) or Hispanic
women (6.2%), even though the socio-
economic status of Hispanic and AA
women was similar.44
Preeclampsia among more recent
African immigrants to other countries
Large numbers of Africans have migrated
to Europe and other high-income coun-
tries, mainly in the past 50 years. Ob-
stetric outcomes for these recent African
immigrants are informative, particularly
because these births often take place
in countries with good records and uni-
versal health care systems (Table 3). For
example, a large study of more than
100,000 women who immigrated to
Ontario between 1985 and 2000 showed
that the racial groups with the highest
risk of severe preeclampsia were from
the Caribbean or SSA.49
Similar ﬁndings were made in The
Netherlands where the highest risk for
eclampsia and preeclampsia was from
women from SSA.50,51 Cape Verdean and
Antillean women were also at higher risk
of preeclampsia in a report from Rotter-
dam, The Netherlands.52 A large number
of Ethiopians have settled in Israel since
the 1980s where prenatal and obstetric
care is standardized with equal medical
insurance, and in this group severe pre-
eclampsia was more likely to occur.53
TABLE 3
Preeclampsia studies among recent African immigrants to other countries
Cohort size
(total/Africans)
Preeclampsia,
OR or RR (95% CI) African origin Comments Location Reference
118,849/15,218 3.34 (2.25e4.96) Caribbean Adjusted for maternal characteristics Canada 49
118,849/9130 3.14 (2.04e4.83) SSA Adjusted for maternal characteristics Canada 49
2413/317 2.40 (1.10e5.60) SSA, Surinam,
Antilles
Univariate analysis The Netherlands 50
2506/29 2.70 (1.20e6.20) Antilles Eclampsia in cases of SAMM, adjusted for
maternal characteristics and obstetric history
The Netherlands 51
2506/90 6.20 (3.60e10.6) SSA Eclampsia in cases of SAMM, adjusted for
maternal characteristics and obstetric history
The Netherlands 51
6215/331 2.06 (1.04e4.09) Cape Verde Adjusted for maternal characteristics and
obstetric history
The Netherlands 52
6215/264 1.87 (0.86e4.06) Antilles Adjusted for maternal characteristics
and obstetric history
The Netherlands 52
1728/576 2.47 (1.02e6.00) Ethiopia Standardized care between the groups
compared
Israel 53
76,158/11,395 2.60 (2.32e2.92) Caribbean Adjusted for maternal characteristics
and obstetric history
United Kingdom 54
8366/1581 3.64 (1.84e7.21) n.a. Adjusted for maternal characteristics
and obstetric history
United Kingdom 55
15,639/356 0.90 (0.53e1.51)a SSA No increased risk Sweden 56
165,001/986 n.a. African, Somalia No increased risk Finland 58
526/158 3.90 (1.70e8.94)a SSA Early-onset PE compared to late onset
(<28 or <34 weeks)
France 68
Maternal characteristics generally include maternal age, body mass index, and socioeconomic status. Obstetric history generally includes parity, chronic hypertension, and diabetes.
CI, confidence interval; n.a., not available; OR, odds ratio; PE, preeclampsia; RR, relative risk; SAMM, severe acute maternal morbidity.
a OR was calculated from the data.
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Large groups of women of African
ancestry live in London where access
to National Health Service hospitals is
freely available and home deliveries are
rare. In a survey of 80,000 pregnancies
that included women of European and
Asian ancestry, 15% had African an-
cestry, and this was the second strongest
risk factor for preeclampsia after chronic
hypertension and also carried a higher
risk of other poor obstetric outcomes
such as FGR and stillbirth.54 Similarly,
African ancestry was a risk factor for
early-onset preeclampsia compared with
all other racial groups, and this remained
so, even after adjusting for age, body
mass index, and other maternal charac-
teristics.55 These and other studies of
African immigrants also highlight the
increased risk of GOS such as stillbirths
and FGR similar to AA.56-58
Severity and recurrence
of preeclampsia
The early onset and severity of pre-
eclampsia in women from Uganda is also
a cause of concern, although the latter
may reﬂect the late admittance toMulago
Hospital. In a US national hospital
discharge survey, higher mortality from
preeclampsia and eclampsiawas reported
among women of African ancestry
compared with European Americans, but
only one-third or less of the difference
could actually be attributed to the higher
prevalence.59 Pregnancy-related deaths
from preeclampsia/eclampsia were 3
times higher in AA women compared
with Europeans.60
In the UK Maternal Death Review
for the period 2006-2008, 22 deaths
occurred as a result of preeclampsia and
eclampsia. Despite being a minority
group, 6 of these deaths were Africans
and the authors noted: “Black African
women seem particularly susceptible to
aggressive forms of preeclampsia. To
establish if this is true, and what might
be the underlying genetic or other
pathophysiological mechanisms, further
research is required.”61
After a woman has had preeclampsia
in her ﬁrst pregnancy, the risk of recur-
rence is increased, with a relative risk of
15.0 cited in an authoritative Norwegian
study of more than 2 million women.62
Increased risk of other GOS, even if
preeclampsia does not occur, is also
clear from another large study in Swe-
den, and other reports support this
conclusion.35,63-66
Large studies of this kind are still not
available for African women resident in
SSA, but our own experience in Kampala
is that recurrent preeclampsia does occur
frequently. In London, 23% of 500
women with previous preeclampsia had
recurrent disease that required delivery
before 37 weeks, and African compared
with European ancestry was a signiﬁcant
predictor.67 It also seems that when
preeclampsia does occur in the second
pregnancy in AA women, it is severe,
early-onset disease with associated FGR
and preterm birth.45 A recent study from
France suggests that women of African
ancestry are more at risk for early-onset
preeclampsia and more likely to have
had a previous history of preeclampsia
compared with other groups, including
women from North Africa, despite the
even higher incidence of chronic hyper-
tension in the latter group.68
Summary
Our comprehensive review of the liter-
ature identiﬁed very few papers that run
counter to our conclusion that women of
African ancestry are at increased risk of
developing preeclampsia. First, 3 studies
showed that these women were not at
increased risk of preeclampsia, but they
had low power to detect any effect.56,58,69
Second, the apparent increased suscep-
tibility to preeclampsia among AA has
been dismissed as a problem of incorrect
diagnosis.37 Third, race was discounted
as a signiﬁcant risk factor for pre-
eclampsia in another study, but data
regarding AA women were combined
with that for other minority races so that
the analysis could not provide a mean-
ingful comparison.38
Genetics of preeclampsia
That there is a genetic component
to preeclampsia has long been sus-
pected.70-72 Daughters of women with
preeclampsia have more than twice the
risk of developing the disease them-
selves, and sisters of affected women,
even if not born from a preeclamptic
pregnancy, are also at increased risk.73-77
These ﬁndings of familial aggregation in
preeclampsia are also true for the other
GOS.78-81 Although environmental fac-
tors, particularly inﬂuences acting in
utero, are important, some of the risk is
likely to be genetic. Indeed, a study of
female twin pairs with known zygosity
estimated that the heritability of pre-
eclampsia was approximately 54%.82
Could there be particular susceptibility
genes associated with the higher fre-
quency of preeclampsia in women of
African ancestry? A case-control study of
preeclampsia in Latinas, a group with
admixture from European, African, and
native Americans, did show, using
ancestry informative markers, that Afri-
can ancestry was associated with
preeclampsia.83
The role of the fetal (father’s) genes is
less obvious, but many reports indicate a
paternal contribution to the risk.84-87
Intergenerational and familial aggrega-
tion also point to genetic factors derived
from both maternal and fetal genes, with
most risk coming from maternal genes
that may act in either the mother or her
fetus.71,74,77,88 A drive to look for the
susceptibility genes for preeclampsia has
so far been disappointing. The studies
generally have small numbers of subjects
and have not been replicated.89
Genome-wide association screening is
an unbiased approach to look for sus-
ceptibility genes in complex disorders and
has been used in preeclamptic cohorts,
but, although various single-nucleotide
polymorphism candidates have been
identiﬁed, the lack of statistical power is
again a problem.90-93 Systematic meta-
analyses of these studies found 7 single-
nucleotide polymorphisms signiﬁcantly
associated near genes involved in pro-
cesses such as coagulation, the renin-
angiotensin system, and inﬂammation.
This highlights an important issue:
searching for variants associated with
preeclampsia only in the maternal ge-
nome will reveal genes mainly associated
with the tertiary systemic syndrome and
not those maternal and/or fetal genes
involved in physiological transformation
of the arteries or to the subsequent stress
response of the placenta to the reduced
blood ﬂow. The clear increased risk of
Expert Reviews Obstetrics www.AJOG.org
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cardiovascular disease in women who
have had preeclampsia again points to a
separate set of susceptibility genes that
are acting systemically and not during
early placentation.94,95
We have taken a different approach and
focused on the primary defect of poor
placentation. This is based on the idea
that regulation of trophoblast behavior
during placentation is mediated by allo-
geneic recognition of trophoblast major
histocompatibility complex molecules by
maternal lymphocytes.96 The ﬁndings
that specialized immune cells, uterine
natural killer (NK) cells, accumulate at
the site of placentation, together with the
discovery of NK receptors, the killer-cell
immunoglobulin-like receptor family
(KIR) and their cognate HLA-C tropho-
blast ligands have demonstrated how the
mother can discern the presence of a
genetically different individual.97-99
KIR and HLA are the most poly-
morphic gene families in humans, and
we have shown that particular maternal
KIR in combination with fetal HLA-C
variants are associated with preeclampsia
and the other GOS.100-102 Women who
have 2 KIR A haplotypes (KIR AA geno-
type) are at risk when there is a HLA-C
allele belonging to the C2 group in
the fetus. Furthermore, the origin of the
fetalHLA-C2 is important; themost risk is
from a C2 allele inherited from the father.
We are now undertaking a similar
study at Mulago Hospital, and pre-
liminary ﬁndings illustrate the same
maternalKIR/fetalHLA-C combinations
associated with preeclampsia in African
women. Interestingly, the frequency of
the fetal HLA-C2 variant that confers
risk is increased in Ugandans compared
with Europeans and Asians.103 Further-
more, there is enormous variability of
KIR genes in Africans with far more ge-
notypes and more allelic variation at
individual KIR loci.104
How these genetic ﬁndings translate
into the function of uterine NK cells is a
challenge, given the ethical and logistical
difﬁculties in experimenting with these
cells. Functionally, we would predict that
the risky combination results in very
strong inhibition of uterine NK cells
(Figure 1). Triggering of uterine NK cells
by HLA-C2 target cells in vitro from
women who have a protective KIR B
haplotype (in which the activating KIR
for HLA-C2, KIR2DS1, is located) results
in secretion of cytokines and chemokines
that may facilitate trophoblast invasion
and vascular transformation.105 Thus, we
propose that the uterine immune system
using highly variable maternal KIR/fetal
HLA-C interactions subtly deﬁnes the
boundary between mother and baby,
limiting the highly invasive placentawhile
at the same time ensuring the fetus
receives sufﬁcient nourishment for nor-
mal development through remodeling of
the spiral arteries.
The obstetric dilemma
Overall, the data we have brought
together in this review suggest that pre-
eclampsia and other GOS occur more
commonly inwomen of African ancestry
compared with other ethnic groups, and
this is not wholly accounted for by con-
founding social, cultural, and medical
FIGURE 1
Maternal KIR/fetal HLA-C interactions at the site of placentation
In these 2 scenarios, the mother is HLA-C1 homozygous and the fetus has inherited an HLA-C2
group allele from the father. If the mother has a KIR AA genotype that lacks activating KIR and has a
strong inhibitory KIR for HLA-C2 (KIR2DL1), poor placentation results. In contrast, if the mother has a
KIR AB or BB genotype containing the activating KIR for HLA-C2 (KIR2DS1), uterine natural killer cells
are triggered to produce increased amount of cytokines and chemokines (eg, granulocyte-
macrophage colonyestimulating factor) that enhance placentation.
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inﬂuences.50,54,57,68 It also seems that the
risk of preeclampsia in African immi-
grants to Europe is increased irrespective
of their area of origin in Africa, apart
from North Africans.68 All these obser-
vations point to a need to investigate
possible biological/genetic reasons con-
tributing to the higher risk of pre-
eclampsia in SSA.
We would anticipate that there would
be strong selective pressure against a
disorder that, without medical interven-
tion, is frequently fatal to mother and
child and occurs in 5-10% of ﬁrst preg-
nancies. A failure of the physiological
transformation of uterine arteries is a
common feature of all the GOS, and this
results in a reduced placental supply
of oxygen and nutrients, lower birth-
weights, and the risk of preterm labor
and superimposed preeclampsia. How-
ever, at the same time, we have to consider
that maternal and neonatal mortality is
not only high under circumstances of
reduced fetal nutrition but also when
babies are too large for the pelvis.
Compared with other primates, the
passage of the large human fetal head
through a bony pelvis is a tight ﬁt,
requiring rotation of the head as it goes
through the birth canal as a consequence
of adaptation to bipedalism.106,107 The
high maternal and neonatal mortality
associated with extremes of birthweight,
sometimes called the obstetric dilemma,
has been described as “perhaps the
most clear-cut example of a human
character subject to stabilizing selection”
(Figure 2).108
The optimal survival of babies weigh-
ing between 6 and 8 lb (2.5-3.5 kg) seems
to be a universal feature of human pop-
ulations. If babies become too large, the
risk of obstructed labor is increased. As
in the rest of SSA, at Mulago Hospital we
not only have many disordered preg-
nancies arising from failure of placenta-
tion, but we also experience frequent
births with prolonged obstructed labor
because of cephalopelvic disproportion.
Without cesarean section, this leads to
birth asphyxia, postpartum hemorrhage,
pelvic trauma, sepsis, and long-term
problems such as vesicovaginal ﬁs-
tula.109 In Uganda, 2% of all women
have had an obstetric ﬁstula.6 Therefore,
the higher cesarean section rates seen in
high-income countries in women of
African ancestry may reﬂect not just
delivery of women with preeclampsia
but also an increased frequency of
obstructed labor.24,54,58,110
A detailed audit from the Royal Col-
lege of Obstetricians and Gynaecologists
in the United Kingdom highlighted the
higher cesarean section rates in women
of African ancestry, even when con-
founders such as age, parity, birthweight,
and presentation were considered.110
Furthermore, shoulder dystocia has also
been reported to occur more commonly
in AA women.111
These ﬁndings may in part be
accounted for by measurements of the
bony pelvis revealing that there is even
less room for the fetal head in women of
African ancestry. Although pelvimetry
may not be a useful indicator in pre-
dicting cephalopelvic disproportion in
individual patients,112 themeasurements
made of the pelvis, notably the pelvic
inlet, outlet, length of sacrum, and pelvic
ﬂoor area, are all smaller in women of
African ancestry compared with those of
European ancestry.113-115
A possible consequence is that the
fetal head engages into the pelvis late,
only when labor commences, whereas
this occurs in the last month of gestation
in European and Asian women.116
Several reports also document the fact
that normal term in African pregnancy
occurs at only approximately 38 weeks’
gestation, which is 2 weeks earlier than
in non-Africans, possibly facilitating
birth before the baby becomes too
big.117-120 If births are occurring earlier,
it would certainly then be advantageous
for the fetus to mature more quickly,
and indeed, African babies frequently
pass meconium with no sign of fetal
distress.119,121 There is also accelerated
lung maturity.122,123 Thus, the difﬁ-
culties imposed by the birth process and
the passage of the head and shoulders
through the bony pelvis seem to have
driven biological changes in many as-
pects of pregnancy.
FIGURE 2
Birthweight and neonatal mortality rates (n[ 13,730).
Adapted, with permission, from Cavalli-Sforza and Bodmer.108
Nakimuli. Pregnancy, parturition and preeclampsia in Africa. Am J Obstet Gynecol 2014.
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This clear trade-off between the size of
the pelvis and head room will beneﬁt
babies who have intermediate birth-
weights, and the 2 extremes with re-
duced survival will be selected against.
Of interest will be a study of maternal
KIR/fetal HLA-C variants in pregnancies
with obstructed labor as the KIR A and B
haplotypes and HLA-C1 and C2 groups
are under stabilizing selection and are
found at different frequencies across the
world’s populations.124
Therefore, when considering why pre-
eclampsia persists in populations, it is
important not only to consider the GOS
but also the morbidity and mortality at
the other end of the birth weight distri-
bution. It may be that the consequences
of these contrasting selective pressures
not only affect higher birthweight babies
but also the tendency for enhanced
numbers of undernourished babies with
the concomitant maternal syndrome of
preeclampsia. That is to say that selection
in a population for reduced fetal size may
lead to the persistence of factors predis-
posing to preeclampsia.
Future directions
There is an urgent need to document
obstetric events better in SSA, and the
lack of detailed electronic hospital re-
cords in the hospitals as well as the fail-
ure to record all births in the population
is a major difﬁculty for any maternal
health research program. For example,
proper assessment of gestational age at
delivery will be crucial in the accurate
diagnosis of the GOS. The record systems
documenting obstetric and neonatal
problems are still inadequate throughout
SSA, and this is clearly a major priority.
Introduction of record systems in
Zambia had an immediate impact on
health care such as penicillin adminis-
tration for syphilis as well as highlighting
the shorter gestational age and describing
the normal birthweight distribution.125
The majority of studies on pre-
eclampsia and the other GOS are from
Europe and the Americas, but if these
conditions are indeed occurring at greater
frequency in women of African ancestry,
it makes scientiﬁc and economic sense to
study them in the setting in which they
have a major impact. Furthermore, the
out-of-Africa migrations have reduced
the extent of genetic variation in the Eu-
ropean populations that are the focus of
the great majority of studies of pregnancy
disorders.
Studying biological diversity will shed
light on pathological pregnancies in all
populations, and inclusion of African
women into research on preeclampsia
is an essential component in tackling
this major disparity of maternal health. It
has been highlighted that “Africa is a
genetically special place” with greater ge-
netic diversity and lower levels of linkage
disequilibrium.126 The genes contributing
to defective placentation are therefore
likely to become obvious more quickly.
Indeed, our initial study of KIR genes has
found amuch greater number of different
KIR haplotypes in women delivering at
Mulago Hospital but also highlighted the
extent of variability of these genes within
the African continent.103 Denying the
existence of genetic differences in Africans
and their interactions with nongenetic
factors only delays the identiﬁcation of the
causal genes or alleles that would allow us
to move away from racial/ethnic catego-
rization of individuals. Knowing the ge-
netic variants will allow a better
understanding of the molecular pathways
and better health care for the women
carrying the risky genotypes, indepen-
dently from their ethnicity. -
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Appendix
Glossary
Genetic admixture: phenomenon of
interbreeding between members of 2 or
more different populations resulting in
the exchange of genes.
Genome-wide association: a search
for common genetic variants associated
with a disease. Generally, the association
of particular single-nucleotide poly-
morphism (SNPs), variation in the DNA
sequence of a single nucleotide, is ana-
lyzed in individuals with the disease
compared with normal matched control
subjects.
Great obstetrical syndromes: major
pregnancy complications such as spon-
taneous abortion, fetal death, abruptio
placentae, fetal growth failure, pre-
eclampsia, preterm labor, and premature
rupture of membranes. These disorders
all share the primary defect of failure of
physiological transformation of uterine
spiral arteries, but there aremultiple fetal
and maternal factors that determine the
exact clinical outcome.
HLA-C: polymorphic classical HLA
class I molecules present at the surface of
most nucleated cells and also expressed
by invasive trophoblast cells at the site
of placentation. HLA-C molecules are
important ligands for KIR receptors.
Killer cell immunoglobulin-like
receptors (KIR): a family of closely
related genes located in the leukocyte
receptor complex on chromosome 19.
KIR proteins are expressed on the sur-
face of NK cells. KIR can have an acti-
vating or inhibitory effect on NK cell
function. In all populations, 2 types of
KIR haplotypes are found; KIR A hap-
lotypes contain mainly inhibitory KIR,
whereas KIR B haplotypes contain extra,
mainly activating, KIR.
Linkage disequilibrium: differences
in a population between the observed
occurrence of some combinations of
alleles or genetic markers and their
expected frequencies under the assump-
tion of independence. Linkage disequi-
librium is expected to be the greatest for
2 genes located closely together on a
chromosome.
NK cells: large granular lymphocytes
of the innate immune system that play
important roles in defense against viral
infections and tumors. A specialized
subset of NK cells amass at the site of
placentation early in gestation.
Positive selection: type of natural se-
lection that results in the increase of the
frequency of the advantageous alleles
over time.
Stabilizing selection: selection favor-
ing intermediate values of a character
over the extremes.
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